Skip to main content

Cryptolepine

ADVERTISEMENT
Identification
Molecular formula
C16H17N3O2
CAS number
552-66-9
IUPAC name
6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
State
State
Cryptolepine is typically a solid at room temperature, exhibiting its stable form as a powder or crystalline solid.
Melting point (Celsius)
264.00
Melting point (Kelvin)
537.15
Boiling point (Celsius)
542.70
Boiling point (Kelvin)
815.85
General information
Molecular weight
294.33g/mol
Molar mass
294.3290g/mol
Density
1.3348g/cm3
Appearence

Cryptolepine appears as pale yellow to brown powder or crystalline solid. It is known for its characteristic appearance under various lighting conditions and may exhibit fluorescence depending on its chemical composition and physical state.

Comment on solubility

Solubility of 6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

The solubility of 6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol can vary significantly depending on the solvent in question. Analyzing the factors that affect its solubility provides insight into its chemical behavior:

  • Polarity of Solvent: The solubility may be enhanced in polar solvents, as the presence of hydroxyl groups can interact favorably with water.
  • Temperature: Increasing temperature generally increases solubility for many compounds, so testing at elevated temperatures could yield different results.
  • Functional Groups: The presence of hydroxyl (-OH) groups indicates that this compound could form hydrogen bonds, facilitating solubility in alcohols or other protic solvents.
  • Concentration: Concentrating enough compound in solution is essential to observe and quantify its solubility effectively.
  • pH Considerations: The solubility may change in response to pH adjustments, especially if the compound can ionize under acidic or basic conditions.

In conclusion, understanding the solubility of 6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol requires consideration of various interacting factors. It’s often beneficial to conduct empirical tests under varying conditions to acquire a comprehensive perspective. As the saying goes, "the solvent makes the solute," and this phrase profoundly underscores the relevance of solubility in chemical interactions.

Interesting facts

Exploring 6-Propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol

6-Propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol, a fascinating compound belonging to the family of quinoline derivatives, showcases intriguing properties that contribute to its significance in various fields of study. Here are some interesting facts about this unique compound:

Structural Characteristics

  • Polycyclic Structure: The compound features a complex polycyclic framework, which provides a rich area for interaction with biological systems.
  • Chirality: With multiple stereocenters, this compound can exist as enantiomers with potentially different biological activities.

Biological Relevance

  • Medicinal Potential: Compounds in this class have been studied for their pharmacological properties, including anti-cancer and anti-inflammatory effects.
  • Cognitive Function: Some derivatives have shown promise in enhancing cognitive function and providing neuroprotective effects, making them a subject of interest in neurochemistry.

Research Applications

  • Organic Synthesis: The unique structural attributes make it a useful intermediate in the synthesis of more complex organic molecules.
  • Pharmaceutical Development: Continuous research is being conducted to optimize its derivatives for improved therapeutic effectiveness.

This compound not only stands out due to its intricate molecular design but also captivates researchers with its vast potential applications in medicinal chemistry and drug discovery. As we advance our understanding of such compounds, the insights gained may lead to breakthroughs in treating various diseases and enhancing human health.

Synonyms
57559-68-9
AZ9L8ZYZ3A
(+-)-N-Propylnorapomorphine
10,11-Dihydroxy-6-propylnoraporphine
(+-)-N-n-Propylnorapomorphine
UNII-AZ9L8ZYZ3A
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-propyl-
6-Propyl- 5,6,6a,7-tetrahydro-4H-dibenzo(de,g)quinoline-10,11-diol
6-Propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-propyl-, (+-)-
GTPL934
SCHEMBL249729
(A+/-)-N-Propylnorapomorphine
SCHEMBL29447877
DTXSID001311565
PDSP1_000787
PDSP2_000775
PROPYLNORAPOMORPHINE, (+/-)-
(+/-)-N-N-PROPYLNORAPOMORPHINE
NCGC00162153-01
NCGC00162153-02
NS00015459
L000005
Q27088032